Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/13/2025 | $40.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
| 4/3/2025 | $9.00 | Neutral | B. Riley Securities |
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc |
Citizens JMP upgraded Global Medical REIT from Mkt Perform to Mkt Outperform and set a new price target of $40.00
B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to "Chiron Real Estate Inc." Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the "NYSE") under the new name, "Chiron Real Estate Inc.," and ticker symbol "XRN." "After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission," Mark Decker, Jr., Chief Executive Officer, said. "Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered a
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to reflect the Company's one-for-five reverse stock split that was effective on September 19, 2025. Stockholders should review their Forms 1099 as well as other 2025 tax statements that they will receive from their brokerage firms or o
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that Henry Cole has notified the Board of Directors (the "Board") that he plans to step down as a member of the Board at the end of his current term. Henry Cole's Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company's inception and has served at different points throughout his term as the Board's Lead Independent Director, Chair of the Board's Compensation Committee and ESG Committee and as a member of the Board's Audit and Nominating and Corporate Governance Committees. Mr. Cole will be stepping down effective at the end of his current term, wh
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
CERT - Global Medical REIT Inc. (0001533615) (Filer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that Ronald Marston has notified the Board of Directors (the "Board") that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at different points throughout his tenure has served as the chair of the Board's Nominating and Corporate Governance Committee as well as a member of the Board's Audit and Compensation Committees. Mr. Marston's retirement will be effective
Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to "Chiron Real Estate Inc." Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the "NYSE") under the new name, "Chiron Real Estate Inc.," and ticker symbol "XRN." "After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission," Mark Decker, Jr., Chief Executive Officer, said. "Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered a
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to reflect the Company's one-for-five reverse stock split that was effective on September 19, 2025. Stockholders should review their Forms 1099 as well as other 2025 tax statements that they will receive from their brokerage firms or o
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that Henry Cole has notified the Board of Directors (the "Board") that he plans to step down as a member of the Board at the end of his current term. Henry Cole's Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company's inception and has served at different points throughout his term as the Board's Lead Independent Director, Chair of the Board's Compensation Committee and ESG Committee and as a member of the Board's Audit and Nominating and Corporate Governance Committees. Mr. Cole will be stepping down effective at the end of his current term, wh
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)